http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2303462-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d8f92aa0ff8435241c22c947f95e823
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-00
filingDate 2005-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9598483d2c60e1903b8b69f5ed4dd9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ebff2e28fd5d27914aa4378a928f37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63da2e2e322b0ec6242ca827c8075bdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c4086f0ea35515d110fb251123fe206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c6f089cb10312b48f41934c171da683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3f8eda682a8479ba45cfc5c82ea02eb
publicationDate 2008-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2303462-A1
titleOfInvention NEW PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICALLY PURE OLANZAPINE POLYMORPHIC FORM I.
abstract New procedure for the preparation of anFolimorphic form I of pharmaceutically pure olanzapine.n n n The invention relates to a new methodnto prepare crystalline form I of olanzapine, in whichndissolve olanzapine crude in a water miscible solvent innwhich is easily soluble, from which form I is obtainednof substantially pure olanzapine by precipitation.
priorityDate 2004-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0733635-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0218390-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004058773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5229382-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03101997-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 45.